Christopher Cooney, Principal Investigator on the director and grant of Engineering in Akonni Biosystems. ‘The advantage of this manufacturing approach is that Lab-on-a-Film microarray production and assembly could be automated at very high speeds, resulting in ten – to one hundred-fold savings in consumable costs.’ Related StoriesUCSF-led researchers map out melanoma's genetic trajectoriesNew clinical trial on breast cancer may help treat and control diseaseBerkeley Lab scientists identify genetic factors that influence neurological disorders and bodyweight Lab-on-a-Film manufacturing has the potential to produce mid-multiplexed microarray consumables for just a few dollars. Combining low-cost creation with the multiplexing power of Akonni’s gel-drop microarrays, to concurrently interrogate tens to hundreds of disease markers in a single clinical sample, offers the potential to improve the economics of patient wellness disease and monitoring medical diagnosis.By focusing on a limited set of genes, we are able to increase our sequencing depth and reduce overall sequencing expenditure. Agilent’s collaboration with Dr. Bernards has resulted in the advancement of a individual kinome package that enriches for the most comprehensive set of kinase and kinase-related genes, said Emily LeProust, Ph.D., Agilent director, Applications and Chemistry R&D – – Genomics. The package will enable scientists to effectively map mutations over the genome, accelerate biomarker discovery and allow for better stratification of individual populations.